{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:25:42Z","timestamp":1783023942467,"version":"3.54.6"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    Glucagonoma is a rare pancreatic neuroendocrine tumor characterized by necrolytic migratory erythema (NME), diabetes, and weight loss. Diagnosis can be difficult, especially when serum glucagon levels are normal. We report a case of a 49-year-old woman with chronic pruritic skin lesions and significant weight loss. Skin biopsy confirmed NME, while laboratory tests showed hyperglycemia and normal serum glucagon. A\n                    <jats:sup>68<\/jats:sup>\n                    Ga-DOTANOC PET\/CT scan revealed a somatostatin receptor-expressing mass in the pancreas. Surgical resection confirmed a grade 2 pancreatic NET consistent with glucagonoma, emphasizing that normal glucagon levels do not rule out glucagonoma and highlighting the utility of SSTR PET\/CT in diagnosis.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006259","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T08:00:18Z","timestamp":1775462418000},"page":"e608-e609","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Somatostatin Receptor PET\/CT in a Glucagonoma Presenting With Necrolytic Migratory Erythema and Normoglucagonemia"],"prefix":"10.1097","volume":"51","author":[{"given":"Srinivas Ananth","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1477-7819-12-220","article-title":"Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor","volume":"12","author":"Wu","year":"2014","journal-title":"World J Surg Oncol"},{"key":"R2-20260702","first-page":"1484089","article-title":"Glucagonoma and glucagonoma syndrome: a case report with review of recent advances in management","volume":"2016","author":"Al-Faouri","year":"2016","journal-title":"Case Rep Surg"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/ijd.13947","article-title":"A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema","volume":"57","author":"Tolliver","year":"2018","journal-title":"Int J Dermatol"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-4632.2009.04220.x","article-title":"Glucagonoma syndrome and necrolytic migratory erythema","volume":"49","author":"Lobo","year":"2010","journal-title":"Int J Dermatol"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S0365-05962013000100001","article-title":"Paraneoplastic cutaneous manifestations: concepts and updates","volume":"88","author":"Silva","year":"2013","journal-title":"An Bras Dermatol"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jdv.13752","article-title":"Glucagonoma syndrome: a review and update on treatment","volume":"30","author":"John","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s11606-013-2490-5","article-title":"Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome","volume":"28","author":"Halvorson","year":"2013","journal-title":"J Gen Intern Med"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.radcr.2019.10.007","article-title":"Molecular imaging of a glucagonoma with 18F-FDG PET\/CT and 68Ga-DOTATATE PET\/CT imaging: a case report and review of the literature","volume":"15","author":"Fathala","year":"2019","journal-title":"Radiol Case Rep"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/ajco.12048","article-title":"Necrolytic migratory erythema associated with glucagonoma syndrome diagnosed by 68Ga-DOTANOC PET-CT","volume":"10","author":"Sahoo","year":"2014","journal-title":"Asia Pac J Clin Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:02:11Z","timestamp":1783022531000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006259"}},"subtitle":["A Diagnostic Dilemma"],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006259","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"2025-07-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}